139 related articles for article (PubMed ID: 37777542)
1. IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia.
Zheng K; Sha N; Hou G; Leng Z; Zhao Q; Zhang L; He L; Xu M; Jiang Y; Chen T
Nat Commun; 2023 Sep; 14(1):6117. PubMed ID: 37777542
[TBL] [Abstract][Full Text] [Related]
2. Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia.
Fang K; Sun M; Leng Z; Chu Y; Zhao Z; Li Z; Zhang Y; Xu A; Zhang Z; Zhang L; Chen T; Xu M
J Exp Clin Cancer Res; 2023 Mar; 42(1):73. PubMed ID: 36978187
[TBL] [Abstract][Full Text] [Related]
3. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.
Barber MF; Michishita-Kioi E; Xi Y; Tasselli L; Kioi M; Moqtaderi Z; Tennen RI; Paredes S; Young NL; Chen K; Struhl K; Garcia BA; Gozani O; Li W; Chua KF
Nature; 2012 Jul; 487(7405):114-8. PubMed ID: 22722849
[TBL] [Abstract][Full Text] [Related]
4. SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma.
Lee HS; Jung W; Lee E; Chang H; Choi JH; Kim HG; Kim A; Kim BH
J Pathol Transl Med; 2016 Sep; 50(5):337-44. PubMed ID: 27498548
[TBL] [Abstract][Full Text] [Related]
5. LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.
Zhu Z; Song J; Guo Y; Huang Z; Chen X; Dang X; Huang Y; Wang Y; Ou W; Yang Y; Yu W; Liu CY; Cui L
Oncogene; 2020 Jun; 39(24):4666-4680. PubMed ID: 32398865
[TBL] [Abstract][Full Text] [Related]
6. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
[TBL] [Abstract][Full Text] [Related]
7. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.
Chen S; Yang X; Yu M; Wang Z; Liu B; Liu M; Liu L; Ren M; Qi H; Zou J; Vucenik I; Zhu WG; Luo J
Neoplasia; 2019 Jul; 21(7):665-675. PubMed ID: 31108370
[TBL] [Abstract][Full Text] [Related]
8. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis.
Jiang L; Xiong J; Zhan J; Yuan F; Tang M; Zhang C; Cao Z; Chen Y; Lu X; Li Y; Wang H; Wang L; Wang J; Zhu WG; Wang H
J Biol Chem; 2017 Aug; 292(32):13296-13311. PubMed ID: 28655758
[TBL] [Abstract][Full Text] [Related]
10. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.
Day BW; Stringer BW; Spanevello MD; Charmsaz S; Jamieson PR; Ensbey KS; Carter JC; Cox JM; Ellis VJ; Brown CL; Walker DG; Inglis PL; Allan S; Reynolds BA; Lickliter JD; Boyd AW
Neuro Oncol; 2011 Nov; 13(11):1202-12. PubMed ID: 21846680
[TBL] [Abstract][Full Text] [Related]
11. Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
Oudaert I; Satilmis H; Vlummens P; De Brouwer W; Maes A; Hose D; De Bruyne E; Ghesquière B; Vanderkerken K; De Veirman K; Menu E
J Exp Clin Cancer Res; 2022 Feb; 41(1):45. PubMed ID: 35105345
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation can regulate the activity of ETS-like transcription factor 4.
Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ
Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912
[TBL] [Abstract][Full Text] [Related]
13. Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.
Qin F; Song Y; Zhang Y; Facemire L; Frierson H; Li H
PLoS One; 2016; 11(3):e0150382. PubMed ID: 26938874
[TBL] [Abstract][Full Text] [Related]
14. ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.
Zhu Z; Guo Y; Liu Y; Ding R; Huang Z; Yu W; Cui L; Du P; Goel A; Liu CY
Adv Sci (Weinh); 2023 Nov; 10(32):e2303378. PubMed ID: 37786278
[TBL] [Abstract][Full Text] [Related]
15. ELK4 Promotes Cell Cycle Progression and Stem Cell-like Characteristics in HPV-associated Cervical Cancer by Regulating the FBXO22/PTEN Axis.
Gao F; Wang C; Bai X; Ji J; Huang X
Balkan Med J; 2023 Oct; 40(6):409-414. PubMed ID: 37519006
[TBL] [Abstract][Full Text] [Related]
16. ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis.
Zheng L; Xu H; Di Y; Chen L; Liu J; Kang L; Gao L
J Transl Med; 2021 Aug; 19(1):342. PubMed ID: 34372882
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
[TBL] [Abstract][Full Text] [Related]
18. CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.
Wang Q; Xie Z; Li C; Xu C; Ding C; Ju S; Chen J; Cui Z; Chen C; Gu B; Wei T; Zhao J
J Mol Histol; 2022 Aug; 53(4):657-667. PubMed ID: 35716330
[TBL] [Abstract][Full Text] [Related]
19. Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress.
Cui B; He B; Huang Y; Wang C; Luo H; Lu J; Su K; Zhang X; Luo Y; Zhao Z; Yang Y; Zhang Y; An F; Wang H; Lam EW; Kelley KW; Wang L; Liu Q; Peng F
Cell Death Dis; 2023 Oct; 14(10):682. PubMed ID: 37845207
[TBL] [Abstract][Full Text] [Related]
20. Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions.
Westbrook RL; Bridges E; Roberts J; Escribano-Gonzalez C; Eales KL; Vettore LA; Walker PD; Vera-Siguenza E; Rana H; Cuozzo F; Eskla KL; Vellama H; Shaaban A; Nixon C; Luuk H; Lavery GG; Hodson DJ; Harris AL; Tennant DA
Cell Rep; 2022 Feb; 38(5):110320. PubMed ID: 35108535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]